Publications

The Sex Influence on Response to Tumor Necrosis Factor-α Inhibitors and Remission in Axial Spondyloarthritis.
J Rheumatol 2018 Feb;45(2):195-201
From the Dipartimento di Medicina e Scienze della Salute "Vincenzo Tiberio," Università degli Studi del Molise, Campobasso; Day Hospital of Rheumatology, Azienda Sistema Socio Sanitario (ASST) Centro Specialistico Ortopedico Traumatologico G. Pini-Centro Specialistico Traumatologico-Ortopedico (CTO), Milan; Rheumatology Department of Lucania, San Carlo Hospital of Potenza and Madonna delle Grazie Hospital of Matera, Matera; La Struttura Semplice Dipartimentale (SSD) di Medicina e Reumatologia, Istituto Ortopedico Rizzoli, Università di Bologna, Bologna; Rheumatology Unit, Department of Clinical and Experimental Medicine (DIMED), University of Padua, Padua; Rheumatology Unit, Azienda Ospedaliera-Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) di Reggio Emilia and Università di Modena e Reggio Emilia, Reggio Emilia, Italy.

Residual disease activity in rheumatoid arthritis patients treated with subcutaneous biologic drugs that achieved remission or low disease activity: a longitudinal observational study.
Clin Rheumatol 2018 Feb 21. Epub 2018 Feb 21.
Dipartimento di Medicina e Scienze della Salute "Vincenzo Tiberio", Università degli Studi del Molise, Via Giovanni Paolo II, C/da Tappino, 86100, Campobasso, Italy.

Minimal Disease Activity as a Treatment Target in Psoriatic Arthritis: A Review of the Literature.
J Rheumatol 2018 Jan 15;45(1):6-13. Epub 2017 Nov 15.
From Sorbonne Universités, UPMC Univ Paris 06; Department of Rheumatology, AP-HP, Pitié Salpêtrière Hospital, Paris, France; Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds and UK National Institute for Health Research (NIHR) Leeds Musculoskeletal Biomedical Research Unit, Leeds, UK; V.A. Nasonova Research Institute of Rheumatology, Moscow, Russia; Dipartimento di Medicina e Scienze della Salute, Università degli Studi del Molise, Campobasso, Italy; Hospital Universitario La Paz, Rheumatology Department, Madrid, Spain; Copenhagen Center for Arthritis Research, Center for Rheumatology and Spine Diseases, Rigshospitalet, Glostrup; Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark; Rheumatology University Hospital Frankfurt and Project Group Translational Medicine and Pharmacology TMP, Fraunhofer Institute for Molecular Biology and Applied Ecology IME, Goethe University Frankfurt am Main, Frankfurt, Germany.



The Sex Influence on Response to Tumor Necrosis Factor-α Inhibitors and Remission in Axial Spondyloarthritis.
J Rheumatol 2017 Nov 15. Epub 2017 Nov 15.
From the Dipartimento di Medicina e Scienze della Salute "Vincenzo Tiberio," Università degli Studi del Molise, Campobasso; Day Hospital of Rheumatology, Azienda Sistema Socio Sanitario (ASST) Centro Specialistico Ortopedico Traumatologico G. Pini-Centro Specialistico Traumatologico-Ortopedico (CTO), Milan; Rheumatology Department of Lucania, San Carlo Hospital of Potenza and Madonna delle Grazie Hospital of Matera, Matera; La Struttura Semplice Dipartimentale (SSD) di Medicina e Reumatologia, Istituto Ortopedico Rizzoli, Università di Bologna, Bologna; Rheumatology Unit, Department of Clinical and Experimental Medicine (DIMED), University of Padua, Padua; Rheumatology Unit, Azienda Ospedaliera-Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) di Reggio Emilia and Università di Modena e Reggio Emilia, Reggio Emilia, Italy. Supported by the Gruppo di Studio Spondiloartriti e Artropatia Psoriasica - Antonio Spadaro. All authors are members of this group. E. Lubrano, MD, PhD, Dipartimento di Medicina e Scienze della Salute "Vincenzo Tiberio," Università degli Studi del Molise; F.M. Perrotta, MD, Dipartimento di Medicina e Scienze della Salute "Vincenzo Tiberio," Università degli Studi del Molise; M. Manara, MD, PhD, Day Hospital of Rheumatology, ASST Centro Specialistico Ortopedico Traumatologico G. Pini-CTO; S. D'Angelo, MD, PhD, Rheumatology Department of Lucania, San Carlo Hospital of Potenza and Madonna delle Grazie Hospital of Matera; O. Addimanda, MD, PhD, SSD di Medicina e Reumatologia, Istituto Ortopedico Rizzoli, Università di Bologna; R. Ramonda, MD, PhD, Rheumatology Unit, DIMED, University of Padua; L. Punzi, MD, PhD, Rheumatology Unit, DIMED, University of Padua; I. Olivieri, MD, Rheumatology Department of Lucania, San Carlo Hospital of Potenza and Madonna delle Grazie Hospital of Matera; C. Salvarani, MD, IRCCS di Reggio Emilia and Università di Modena e Reggio Emilia; A. Marchesoni, MD, PhD, Day Hospital of Rheumatology, ASST Centro Specialistico Ortopedico Traumatologico G. Pini-CTO. Dr. Ignazio Olivieri died July 28, 2017. Address correspondence to Dr. E. Lubrano, Dipartimento di Medicina e di Scienze della Salute "Vincenzo Tiberio," Università degli Studi del Molise, Via Giovanni Paolo II, C/da Tappino, 86100 Campobasso, Italy. E-mail: Accepted for publication September 12, 2017.



An ultrasonographic study of enthesis in early psoriatic arthritis patients naive to traditional and biologic DMARDs treatment.
Rheumatol Int 2016 Nov 6;36(11):1579-1583. Epub 2016 Sep 6.
Dipartimento di Medicina e di Scienze della Salute "Vincenzo Tiberio", Università degli Studi del Molise, Via Giovanni Paolo II, C/da Tappino, 86100, Campobasso, Italy.

Latent tuberculosis infection detection and active tuberculosis prevention in patients receiving anti-TNF therapy: an Italian nationwide survey.
Int J Rheum Dis 2016 Aug 14;19(8):799-805. Epub 2015 Jul 14.
Department of Internal Medicine and Medical Specialties, Rheumatology Division - "La Sapienza", University of Rome, Rome, Italy.


Minimal Disease Activity and Remission in Psoriatic Arthritis Patients Treated with Anti-TNF-α Drugs.
J Rheumatol 2016 Feb 15;43(2):350-5. Epub 2015 Dec 15.
From the Academic Rheumatology Unit, Department of Medicine and Health Science Vincenzo Tiberio, University of Molise, Campobasso; Rheumatology Unit, Orthopedic Institute G. Pini, Milan, Italy.F.M. Perrotta, MD, PhD, fellow in Translational and Clinical Medicine, Academic Rheumatology Unit, Department of Medicine and Health Science Vincenzo Tiberio, University of Molise; A. Marchesoni, MD, Consultant Rheumatologist, Rheumatology Unit, Orthopedic Institute G. Pini; E. Lubrano, MD, PhD, Aggregate Professor of Rheumatology and Consultant Rheumatologist, Academic Rheumatology Unit, Department of Medicine and Health Science Vincenzo Tiberio, University of Molise.

Patient's Global Assessment as an Outcome Measure for Psoriatic Arthritis in Clinical Practice: A Surrogate for Measuring Low Disease Activity?
J Rheumatol 2015 Dec 1;42(12):2332-8. Epub 2015 Nov 1.
From the Academic Rheumatology Unit, Department of Medicine and Health Sciences, University of Molise, Campobasso; Department of Clinical and Medical Therapy, Sapienza University, Rome; Rheumatology Unit, Orthopedic Institute G. Pini, Milan, Italy.E. Lubrano, MD, PhD, Aggregate Professor of Rheumatology, Academic Rheumatology Unit, Department of Medicine and Health Sciences, University of Molise; F.M. Perrotta, MD, Specialist Registrar, Department of Clinical and Medical Therapy, Sapienza University; W.J. Parsons, MSC, MPH, Medical Statistician, Academic Rheumatology Unit, Department of Medicine and Health Sciences, University of Molise; A. Marchesoni, MD, Consultant Rheumatologist, Rheumatology Unit, Orthopedic Institute G. Pini.

Psoriatic Disease: Clinical Staging.
J Rheumatol Suppl 2015 Nov;93:24-6
From the Rheumatology Unit, Department of Clinical Medicine and Surgery, University Federico II, Naples, and Academic Rheumatology Unit, Department of Medicine and Health Sciences, University of Molise, Campobasso, Italy.R. Scarpa, MD, Rheumatology Unit, Department of Clinical Medicine and Surgery, University Federico II; F. Caso, MD, PhD, Rheumatology Unit, Department of Clinical Medicine and Surgery, University Federico II, and Rheumatology Unit, Department of Medicine DIMED, University of Padua; L. Costa, MD; R. Peluso, MD, PhD; A. Spanò, MD, Department of Clinical Medicine and Surgery, University Federico II; E. Lubrano, MD, PhD, Academic Rheumatology Unit, Department of Medicine and Health Sciences, University of Molise; A. Del Puente, MD, PhD, Department of Clinical Medicine and Surgery, University Federico II; J.M. Moll, DM, PhD, FRCP, Emeritus Consultant Rheumatologist.

Relationship of Psoriatic Arthritis to Other Spondyloarthritides.
J Rheumatol Suppl 2015 Nov;93:33-5
From the Rheumatology Department of Lucania, San Carlo Hospital of Potenza and Madonna delle Grazie Hospital of Matera, Potenza and Matera; and the Academic Rheumatology Unit, Department of Medicine and Health Sciences, University of Molise, Campobasso, Italy.I. Olivieri, MD, Consultant, Director, Rheumatology Department of Lucania, San Carlo Hospital of Potenza and Madonna delle Grazie Hospital of Matera; S. D'Angelo, MD, Researcher, Rheumatology Department of Lucania, San Carlo Hospital of Potenza and Madonna delle Grazie Hospital of Matera; M. Gilio, MD, Researcher, Rheumatology Department of Lucania, San Carlo Hospital of Potenza and Madonna delle Grazie Hospital of Matera; C. Palazzi, MD, Senior Investigator, Rheumatology Department of Lucania, San Carlo Hospital of Potenza and Madonna delle Grazie Hospital of Matera; E. Lubrano, MD, PhD, Senior Lecturer, Academic Rheumatology Unit, Department of Medicine and Health Sciences, University of Molise; A. Padula, MD, Senior Registrar, Rheumatology Department of Lucania, San Carlo Hospital of Potenza and Madonna delle Grazie Hospital of Matera.

The Definition and Measurement of Axial Psoriatic Arthritis.
J Rheumatol Suppl 2015 Nov;93:40-2
From the Academic Rheumatology Unit, Department of Medicine and Health Sciences, University of Molise, Campobasso; Rheumatology Department, Istituto Ortopedico G. Pini, Milan; Rheumatology Department of Lucania, "S. Carlo Hospital," Potenza and Madonna Delle Grazie Matera, Potenza and Matera; Rheumatology Unit, Department of Medical Sciences, University of Cagliari, Cagliari; Rheumatology Unit, Department of Medicine DIMED, University of Padua, Padua; and Rheumatology Unit, Department of Clinical Medicine and Surgery, University Federico II, Naples, Italy.E. Lubrano, MD, PhD, Aggregate Professor of Rheumatology, Academic Rheumatology Unit, Department of Medicine and Health Sciences, University of Molise; W.J. Parsons, BSc, MPH, Medical Statistician, Academic Rheumatology Unit, Department of Medicine and Health Sciences, University of Molise; A. Marchesoni, MD, Consultant Rheumatologist, Rheumatology Department, Istituto Ortopedico G. Pini; I. Olivieri, MD, Consultant Rheumatologist and Head of Rheumatology Department, Rheumatology Department of Lucania, "S. Carlo Hospital," and Madonna Delle Grazie Matera; S. D'Angelo, MD, Consultant Rheumatologist, Rheumatology, Department of Lucania, "S. Carlo Hospital," and Madonna Delle Grazie Matera; A. Cauli, MD, PhD, Aggregate Professor of Rheumatology, Rheumatology Unit, Department of Medical Sciences, University of Cagliari; F. Caso, MD, PhD, Rheumatology Unit, Department of Medicine DIMED, University of Padua; L. Costa, MD, Assistant Professor of Rheumatology, Rheumatology Unit, Department of Medicine DIMED, University of Padua; Rheumatology Unit, Department of Clinical Medicine and Surgery, University Federico II; R. Scarpa, MD, Associate Professor of Rheumatology and Head of Rheumatology Department, Rheumatology Unit, Department of Clinical Medicine and Surgery, University Federico II; L. Brunese, MD, Chair and Professor of Radiology, Department of Medicine and Health Sciences, University of Molise.

Psoriatic Disease: Update on Traditional Disease-modifying Antirheumatic Drugs.
J Rheumatol Suppl 2015 Nov;93:61-4
From the UOC Day Hospital of Rheumatology, G. Pini Orthopedic Institute, Milan; Academic Rheumatology Unit, Department of Medicine and Health Sciences, University of Molise, Campobasso; and the Rheumatology Unit, Department of Medical Sciences, University of Cagliari, Cagliari, Italy.A. Marchesoni, MD, UOC Day Hospital of Rheumatology, G. Pini Orthopedic Institute; E. Lubrano, MD, PhD, Academic Rheumatology Unit, Department of Medicine and Health Sciences, University of Molise; A. Cauli, MD, PhD, Rheumatology Unit, Department of Medical Sciences, University of Cagliari; M. Ricci, MD, UOC Day Hospital of Rheumatology, G. Pini Orthopedic Institute; M. Manara M, MD, UOC Day Hospital of Rheumatology, G. Pini Orthopedic Institute.

New Approaches in Tumor Necrosis Factor Antagonism for the Treatment of Psoriatic Arthritis: Certolizumab Pegol.
J Rheumatol Suppl 2015 Nov;93:70-2
From the Rheumatology Unit, Department of Medical Sciences, Policlinico of the University of Cagliari, Monserrato; Rheumatology Unit, Department of Medicine and Health Sciences, University of Molise, Campobasso; and Azienda Ospedaliero-Universitaria, Day Hospital di Reumatologia, Istituto Ortopedico G. Pini, Milan, Italy.A. Cauli, MD, PhD; M. Piga, MD, Rheumatology Unit, Department of Medical Sciences, Policlinico of the University of Cagliari; E. Lubrano, MD, PhD, Rheumatology Unit, Department of Medicine and Health Sciences, University of Molise; A. Marchesoni, MD, Azienda Ospedaliero-Universitaria, Day Hospital di Reumatologia, Istituto Ortopedico G. Pini; A. Floris, MD; A. Mathieu, MD, Rheumatology Unit, Department of Medical Sciences, Policlinico of the University of Cagliari.

Current evidence in the field of the management with TNF-α inhibitors in psoriatic arthritis and concomitant hepatitis C virus infection.
Expert Opin Biol Ther 2015 May 4;15(5):641-50. Epub 2015 Feb 4.
University of Padova, Department of Medicine DIMED, Rheumatology Unit , Via Giustiniani 2, 35128 Padova , Italy +39 049 8211206 ; +39 049 8214382 ;


Remission in nonradiographic axial spondyloarthritis treated with anti-tumor necrosis factor-α drugs: an Italian multicenter study.
J Rheumatol 2015 Feb 15;42(2):258-63. Epub 2014 Dec 15.
Academic Rheumatology Unit, Department of Medicine and Health Science, University of Molise, Campobasso; Dipartimento di Medicina Interna e Specialità Mediche, L'Unità Operativa Complessa (UOC) di Reumatologia "Sapienza" Università di Roma, Rome; Rheumatology Unit, Orthopedic Institute G. Pini, Milan; Rheumatology Department of Lucania, San Carlo Hospital of Potenza and Madonna delle Grazie Hospital of Matera, Potenza; Rheumatology Unit, Department of Medicine, Dipartimento di Medicina (DIMED), University of Padua, Padua; S.C. Reumatologia, Dipartimento Medicina Interna e Specialità Mediche Arcispedale Santa Maria Nuova, Azienda Ospedaliera-IRCCS di Reggio Emilia, Reggio Emilia, Italy.E. Lubrano, MD, PhD, Academic Rheumatology Unit, Department of Medicine and Health Science, University of Molise; F.M. Perrotta, MD, Dipartimento di Medicina Interna e Specialità Mediche, UOC di Reumatologia "Sapienza" Università di Roma; A. Marchesoni, MD, Rheumatology Unit, Orthopedic Institute G. Pini; S. D'Angelo, MD; I. Olivieri, MD, Rheumatology Department of Lucania, San Carlo Hospital of Potenza and Madonna delle Grazie Hospital of Matera; R. Ramonda, MD; L. Punzi, MD, Rheumatology Unit, DIMED, University of Padua; O. Addimanda, MD; C. Salvarani, MD, S.C. Reumatologia, Dipartimento Medicina Interna e Specialità Mediche Arcispedale Santa Maria Nuova, Azienda Ospedaliera-IRCCS di Reggio Emilia.


Updated guidelines for the management of axial disease in psoriatic arthritis.
J Rheumatol 2014 Nov;41(11):2286-9
From the Department of Medicine, University of Queensland, Australia; Academic Rheumatology Unit, Department of Medicine and Health Sciences, University of Molise, Campobasso, Italy; Rheumatology Unit, Department of Medical Sciences, University of Cagliari, Cagliari, Italy; Rehabilitation Teaching and Research Unit, University of Otago, Wellington, New Zealand; Rheumatology Department of Lucania, San Carlo Hospital of Potenza and Madonna delle Grazie Hospital of Matera, Italy; and University of Toronto and Toronto Western Research Institute, Toronto, Ontario, Canada.P. Nash, MBBS (Hons), FRACP, Department of Medicine, University of Queensland; E. Lubrano, MD, PhD, Academic Rheumatology Unit, Department of Medicine and Health Sciences, University of Molise; A. Cauli, MD, PhD, Rheumatology Unit, Department of Medical Sciences, University of Cagliari; W.J. Taylor, MBChB, PhD, FRACP, Rehabilitation Teaching and Research Unit, University of Otago; I. Olivieri, MD, Rheumatology Department of Lucania, San Carlo Hospital of Potenza and Madonna delle Grazie Hospital of Matera; D.D. Gladman, MD, FRCPC, Professor of Medicine, University of Toronto, Senior Scientist, Toronto Western Research Institute.

Remission in ankylosing spondylitis treated with anti-TNF-α drugs: a national multicentre study.
Rheumatology (Oxford) 2013 Oct 22;52(10):1914-9. Epub 2013 Jul 22.
Dipartimento di Medicina Interna e Specialità Mediche - UOC di Reumatologia - Sapienza - Università di Roma, Azienda Policlinico Umberto I, Viale del Policlinico 155, 00161 Rome, Italy.




The effectiveness and safety of TNF-alpha blockers in the treatment of early psoriatic arthritis: an Italian multicentre longitudinal observational pilot study.
Clin Rheumatol 2011 Aug 1;30(8):1063-7. Epub 2011 Mar 1.
Department of Clinical and Experimental Medicine, Rheumatology Research Unit, Early Psoriatic Arthritis Clinic, University Federico II, via Sergio Pansini no. 5, Naples, Italy.



Switching from infliximab or etanercept to adalimumab in resistant or intolerant patients with spondyloarthritis: a 4-year study.
Rheumatology (Oxford) 2010 Jun 11;49(6):1107-11. Epub 2010 Mar 11.
Department of Clinical and Medical Therapy, Sapienza - Università di Roma, Azienda Policlinico Umberto I, Viale del Policlinico 155, 00161 Rome, Italy.


Psoriatic arthritis spondylitis radiology index: a modified index for radiologic assessment of axial involvement in psoriatic arthritis.
J Rheumatol 2009 May 30;36(5):1006-11. Epub 2009 Mar 30.
Rheumatology and Rehabilitation Research Unit, FondazioneMaugeri, IRCCS, Institute of Telese Terme, Telese Terme, Italy.




Assessment of Response to Treatment, Remission, and Minimal Disease Activity in Axial Psoriatic Arthritis Treated with Tumor Necrosis Factor Inhibitors.
J Rheumatol 2016 05 15;43(5):918-23. Epub 2016 Mar 15.
From the Academic Rheumatology Unit, Department of Medicine and Health Sciences "Vincenzo Tiberio," University of Molise, Campobasso, Italy.E. Lubrano, MD, PhD, Academic Rheumatology Unit, Department of Medicine and Health Sciences "Vincenzo Tiberio," University of Molise; W.J. Parsons, BSc, MPH, Academic Rheumatology Unit, Department of Medicine and Health Sciences "Vincenzo Tiberio," University of Molise; F.M. Perrotta, MD, Academic Rheumatology Unit, Department of Medicine and Health Sciences "Vincenzo Tiberio," University of Molise.

Predictors of Loss of Remission and Disease Flares in Patients with Axial Spondyloarthritis Receiving Antitumor Necrosis Factor Treatment: A Retrospective Study.
J Rheumatol 2016 08 1;43(8):1541-6. Epub 2016 Jun 1.
From the Dipartimento di Medicina e Scienze della Salute "Vincenzo Tiberio," Università degli Studi del Molise, Campobasso; Day Hospital di Reumatologia, ASST Centro Specialistico Ortopedico Traumatologico G. Pini-CTO, Milan; Rheumatology Department of Lucania, San Carlo Hospital of Potenza and Madonna delle Grazie Hospital of Matera, Matera; Rheumatology Unit, Department of Clinical and Experimental Medicine DIMED, University of Padua; Rheumatology Unit, Azienda Ospedaliera-IRCCS di Reggio Emilia and Università di Modena e Reggio Emilia, Reggio Emilia, Italy.E. Lubrano, MD, PhD, Dipartimento di Medicina e Scienze della Salute "Vincenzo Tiberio," Università degli Studi del Molise; F. Massimo Perrotta, MD, Dipartimento di Medicina e Scienze della Salute "Vincenzo Tiberio," Università degli Studi del Molise; M. Manara, MD, PhD, Day Hospital di Reumatologia, ASST Centro Specialistico Ortopedico Traumatologico G. Pini-CTO; S. D'Angelo, MD, PhD, Rheumatology Department of Lucania, San Carlo Hospital of Potenza and Madonna delle Grazie Hospital of Matera; O. Addimanda, MD, PhD, Rheumatology Unit, Department of Clinical and Experimental Medicine DIMED, University of Padua; R. Ramonda, MD, PhD, Rheumatology Unit, Department of Clinical and Experimental Medicine DIMED, University of Padua; L. Punzi, MD, PhD, Rheumatology Unit, Department of Clinical and Experimental Medicine DIMED, University of Padua; I. Olivieri, MD, PhD, Rheumatology Department of Lucania, San Carlo Hospital of Potenza and Madonna delle Grazie Hospital of Matera; C. Salvarani, MD, PhD, Rheumatology Unit, Azienda Ospedaliera-IRCCS di Reggio Emilia, and Università di Modena e Reggio Emilia; A. Marchesoni, MD, PhD, Day Hospital di Reumatologia, ASST Centro Specialistico Ortopedico Traumatologico G. Pini-CTO.

OF